SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-002074
Filing Date
2024-01-23
Accepted
2024-01-23 16:58:39
Documents
1
Period of Report
2023-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4123
  Complete submission text file 0001209191-24-002074.txt   5621
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Issuer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ANNEXON, INC. 180 KIMBALL WAY, SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address
Overdorf Michael (Reporting) CIK: 0001818522 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39402 | Film No.: 24553268